We serve Indazole-3-carboxylic acid CAS:4498-67-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Indazole-3-carboxylic acid
CAS.NO: 4498-67-3
Synonyms:
1-H-indazole-3-carboxylic acid
3-Carboxyindazole
1H-Indazole-3-carboxylic Acid
Indazole-3-carboxylic Acid
Molecular Formula: C8H6N2O2
Molecular Weight: 162.14500
Physical and Chemical Properties:
Density: 1.506 g / cm3
Boiling point: 443.7ºC at 760 mmHg
Melting point: 266-270 ° C (dec.)
Flash point: 222.2ºC
Refractive index: 1.743
Specification:
Appearance: Yellow crystalline powder
Purity:≥99.0%
Loss on drying:≤0.5%
Sulphated ash:≤0.5%
Isatin:≤0.2%
Indazole:≤0.2%
Any unknown impurity:≤0.2%
Total unknown impurity:≤0.2%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Granisetron hydrochloride CAS:107007-99-8
Contact us for information like Indazole-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Indazole-3-carboxylic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Indazole-3-carboxylic Acid Use and application,Indazole-3-carboxylic acid technical grade,usp/ep/jp grade.
Related News: According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.1-Fluoro-2-iodoethane manufacturer What are the symptoms? Coronavirus symptoms can look like the flu — fever, cough, trouble breathing. If you show these symptoms and recently went to China, or have been in contact with someone who visited, experts advise going to the doctor.6-Carboxy-4-methyl-2-propylbenzimidazole supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?3-Hydroxy-3'-nitro-2-naphthanilide vendor Major global airports, including London Heathrow, are monitoring people arriving from China for signs of illness.Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.
